RAFA LABORATORIES LTD
JERUSALEM,
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541714 | $21.14M | 4 |
| 325412 | $20.95M | 1 |
Contract Awards
4 awards found
RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)
THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE FOLLOWING DEVELOPMENT ESSENTIALS: CMC DEVELOPMENT, PRE-CLINICAL AND CLINICAL STUDIES, DEVICE DEVELOPMENT ACTIVITIES, HUMAN FACTORS TESTING, MARKET VIABILITY ASSESSMENTS ALONG WITH ALL ASSOCIATED REGULA
SUPPLEMENTAL FUNDING FOR CLIN 001, REVISE STATEMENT OF WORK, ADD ALT COR, AND ADD ATTACHMENT 7 EO FAR CLAUSE CHANGES.
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT, INCLUDING U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL, OF ATROPINE AUTOINJECTOR FOR PEDIATRIC USE USING AN IMPROVED VERSION OF RAFA LABORATORIES, LTD.S (RAFAS) FDA-APPROVED SI
Business Details
- UEI
- CKDNTKNDPMJ6
- CAGE Code
- 0905A
- Address
- 3 ZEEV LEV
JERUSALEM,
Parent Company
RAFA LABORATORIES LTD
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov